Turning AI Pilots into Enterprise ValueByRamji VasudevanSeptember 18th 2025The key steps for pharma in pivoting from proof-of-concept experimenting to enterprise-scale value.
How AI is Changing the Drug Development JourneyByRamji VasudevanFebruary 22nd 2024While no company has yet achieved the full promise of AI to radically accelerate time to market, meaningful strides are being made across the drug discovery funnel.